{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3902, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/Zju5aJbrUO4_HSoj2O-S2Zd0pxAW3xCJE5NVnLcPW50/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lMDIxYTJkZTkzMzI2NjRjNTA5NDE5N2I0YmMyNDhjZC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/1", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "29c68665-f4f3-4e40-83f7-987ae5012e89", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Introduction to AstraZeneca's pipeline and performance", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/ogPo4jsvESInXRkceUOtdcS6DsOtck4xn-7BZkp-Ylk/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lMDIxYTJkZTkzMzI2NjRjNTA5NDE5N2I0YmMyNDhjZC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/LOs7pdjjxR0QCWEZ4pSRBCiMZpaZpmBXaBGMHPNlk8s/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lMDIxYTJkZTkzMzI2NjRjNTA5NDE5N2I0YmMyNDhjZC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/wfd7EuiZo318ohlxfB28kezfUqOQ4II7KCBkkG3p04I/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lMDIxYTJkZTkzMzI2NjRjNTA5NDE5N2I0YmMyNDhjZC9wMDAxLnBuZw" }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "kpi_overview", "function": "summarize", "notes": "The slide uses a grid layout to present four key performance indicators related to the drug development pipeline.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/2", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "29c68665-f4f3-4e40-83f7-987ae5012e89", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Introduction to AstraZeneca's pipeline and performance", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "timeline", "function": "summarize", "notes": "The slide uses a matrix-like layout to categorize events by time period and event type (regulatory vs. data readout).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/3", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "29c68665-f4f3-4e40-83f7-987ae5012e89", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Introduction to AstraZeneca's pipeline and performance", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "appendix_data", "function": "appendix", "notes": "The slide uses a matrix-like layout to organize drug assets by therapeutic area and development stage (approved vs. pipeline).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/4", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "29c68665-f4f3-4e40-83f7-987ae5012e89", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Introduction to AstraZeneca's pipeline and performance", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "other", "function": "summarize", "notes": "The slide uses a four-column layout to track drug development progress.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/5", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "29c68665-f4f3-4e40-83f7-987ae5012e89", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Introduction to AstraZeneca's pipeline and performance", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "other", "function": "summarize", "notes": "The slide tracks changes in drug development pipeline status since the Q2 2024 update.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/6", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "other", "function": "summarize", "notes": "The slide uses a grid-based layout to list specific drug assets and their indications within each phase column.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/7", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "other", "function": "summarize", "notes": "The slide uses a grid-based layout to represent the drug development pipeline.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/8", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "other", "function": "other", "notes": "The slide uses a grid-based layout to organize drug candidates by development stage. It includes a legend for '# Partnered and/or in collaboration' and a yellow dot for 'Precision medicine approach being explored'.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/9", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "roadmap", "function": "present_framework", "notes": "The slide uses a timeline-like structure to categorize drug development projects by clinical phase.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/10", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-10", "loopMatches": [ { "to": 20, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "0f67caf9-8d3f-43a6-8b4a-a4ea72436731", "evidence": "Emphasis on the importance of innovation and growth", "position": 0, "objective": "Highlighting the cost of inaction in the pharmaceutical industry", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Kanban-style board to visualize drug development stages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/11", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-11", "loopMatches": [ { "to": 20, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "0f67caf9-8d3f-43a6-8b4a-a4ea72436731", "evidence": "Emphasis on the importance of innovation and growth", "position": 0, "objective": "Highlighting the cost of inaction in the pharmaceutical industry", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a color-coded system to distinguish between Oncology, Biopharmaceuticals, and Rare Disease designations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/12", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-12", "loopMatches": [ { "to": 20, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "0f67caf9-8d3f-43a6-8b4a-a4ea72436731", "evidence": "Emphasis on the importance of innovation and growth", "position": 0, "objective": "Highlighting the cost of inaction in the pharmaceutical industry", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/13", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-13", "loopMatches": [ { "to": 20, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "0f67caf9-8d3f-43a6-8b4a-a4ea72436731", "evidence": "Emphasis on the importance of innovation and growth", "position": 0, "objective": "Highlighting the cost of inaction in the pharmaceutical industry", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a color-coded sidebar to indicate the development stage of the drug across different therapeutic areas.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/14", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-14", "loopMatches": [ { "to": 20, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "0f67caf9-8d3f-43a6-8b4a-a4ea72436731", "evidence": "Emphasis on the importance of innovation and growth", "position": 0, "objective": "Highlighting the cost of inaction in the pharmaceutical industry", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide provides a detailed overview of seven specific clinical trials (AEGEAN, ADJUVANT BR.31, PACIFIC-4, PACIFIC-5, PACIFIC-8, ADRIATIC, PACIFIC-9).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/15", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-15", "loopMatches": [ { "to": 20, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "0f67caf9-8d3f-43a6-8b4a-a4ea72436731", "evidence": "Emphasis on the importance of innovation and growth", "position": 0, "objective": "Highlighting the cost of inaction in the pharmaceutical industry", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a standard clinical trial registry format.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/16", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-16", "loopMatches": [ { "to": 20, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "0f67caf9-8d3f-43a6-8b4a-a4ea72436731", "evidence": "Emphasis on the importance of innovation and growth", "position": 0, "objective": "Highlighting the cost of inaction in the pharmaceutical industry", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix, providing detailed clinical trial data for Imfinzi.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/17", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-17", "loopMatches": [ { "to": 20, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "0f67caf9-8d3f-43a6-8b4a-a4ea72436731", "evidence": "Emphasis on the importance of innovation and growth", "position": 0, "objective": "Highlighting the cost of inaction in the pharmaceutical industry", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a standard clinical trial registry format.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/18", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-18", "loopMatches": [ { "to": 20, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "0f67caf9-8d3f-43a6-8b4a-a4ea72436731", "evidence": "Emphasis on the importance of innovation and growth", "position": 0, "objective": "Highlighting the cost of inaction in the pharmaceutical industry", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix section detailing clinical trial status for specific drug assets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/19", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-19", "loopMatches": [ { "to": 20, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "0f67caf9-8d3f-43a6-8b4a-a4ea72436731", "evidence": "Emphasis on the importance of innovation and growth", "position": 0, "objective": "Highlighting the cost of inaction in the pharmaceutical industry", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix, likely from a pharmaceutical investor presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/20", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-20", "loopMatches": [ { "to": 20, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "0f67caf9-8d3f-43a6-8b4a-a4ea72436731", "evidence": "Emphasis on the importance of innovation and growth", "position": 0, "objective": "Highlighting the cost of inaction in the pharmaceutical industry", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a vertical tab structure on the right to categorize the therapeutic area (Oncology).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/21", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide provides a structured overview of three specific clinical trials: DESTINY-Gastric04, 06, and 03.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/22", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix, indicated by the footer and the 'Other' tab in the right-hand navigation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/23", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a standard clinical trial pipeline table format.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/24", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a standard clinical trial registry format for reporting pipeline progress.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/25", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a standard clinical trial registry format for portfolio tracking.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/26", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix, specifically detailing clinical trial status for a specific drug.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/27", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide provides a structured overview of four specific clinical trials (LAURA, ADAURA2, NeoADAURA, FLAURA2).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/28", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide provides a structured overview of five specific clinical trials (SAFFRON, SANOVO, SACHI, SAVANNAH, ORCHARD) including patient counts and trial arms.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/29", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a color-coded sidebar on the right to categorize the drug's development stage (Oncology).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/30", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-30", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide provides a structured overview of five specific clinical trials (TROPION-Breast01 through 05).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/31", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-31", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix, indicated by the footer and the 'Appendix' label.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/32", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-32", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "appendix_data", "function": "appendix", "notes": "The slide is part of an appendix, specifically detailing late-stage development assets in Oncology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/33", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-33", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix, indicated by the page number 34 and the 'Appendix: Glossary' link at the bottom.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/34", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-34", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix section, indicated by the page number and glossary link.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/35", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-35", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix, detailing specific trial designs, patient counts, and status for TROPION-PanTumor trials.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/36", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-36", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a vertical navigation bar on the right to indicate the drug's development stage (Late-stage development) and therapeutic area (Oncology).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/37", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-37", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes trial identifiers (NCT numbers) and status timelines.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/38", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-38", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is an appendix page detailing clinical trial pipeline data for a specific drug.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/39", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-39", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table lists five distinct clinical trials (SERENA-2, SERENA-3, NCT04541433, SERENA-1, NCT04818632).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/40", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-40", "loopMatches": [ { "to": 40, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "dffbb50c-e367-4fbd-9f65-f687fdc06626", "evidence": "Discussion of AstraZeneca's scientific approach and goals", "position": 1, "objective": "Explaining the 'why' behind AstraZeneca's pipeline and portfolio", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix section detailing clinical trial pipelines.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/41", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-41", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 42, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix, specifically detailing late-stage development assets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/42", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-42", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 43, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix, providing detailed clinical trial data for a specific asset.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/43", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-43", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 44, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide provides a structured overview of four specific clinical trials (EvoPAR-Prostate01, EvoPAR-Breast01, PETRA, PETRANHA).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/44", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-44", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 45, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix, providing specific clinical trial data for a drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/45", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-45", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 46, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is an appendix page detailing the clinical development pipeline for a specific drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/46", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-46", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 47, "slideType": "appendix_data", "function": "analyze_data", "notes": "Slide 47 of a presentation deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/47", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-47", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 48, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/48", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-48", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 49, "slideType": "appendix_data", "function": "analyze_data", "notes": "Slide 49 of a presentation deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/49", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-49", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 50, "slideType": "appendix_data", "function": "analyze_data", "notes": "Part of a pipeline appendix deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/50", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-50", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 51, "slideType": "appendix_data", "function": "analyze_data", "notes": "Slide 51 of a presentation deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/51", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-51", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 52, "slideType": "appendix_data", "function": "analyze_data", "notes": "Part of a larger portfolio deck, indicated by the vertical navigation bar on the right.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/52", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-52", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 53, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide is part of an appendix, providing detailed clinical trial data for a specific drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/53", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-53", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 54, "slideType": "appendix_data", "function": "analyze_data", "notes": "Slide 54 of a larger deck, part of the appendix.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/54", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-54", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 55, "slideType": "appendix_data", "function": "analyze_data", "notes": "Slide 55 of a presentation deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/55", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-55", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 56, "slideType": "appendix_data", "function": "analyze_data", "notes": "Part of a clinical pipeline appendix.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/56", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-56", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 57, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide provides a summary of two clinical trials (PRIMROSE and PRIMAVERA) including population, patient counts, design, endpoints, and status.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/57", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-57", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 58, "slideType": "appendix_data", "function": "analyze_data", "notes": "Part of a corporate presentation appendix, specifically under the Oncology pipeline section.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/58", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-58", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5130-7668-92cb-6c77396e6bd2", "docSlug": "e021a2de9332664c5094197b4bc248cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 59, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a standard clinical trial table format common in pharmaceutical investor presentations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/59", "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2", "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-59", "loopMatches": [], "arcBeatMatches": [ { "to": 120, "from": 6, "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-5087-71ae-b0e8-0abfd1317859", "docSlug": "b6fff97596ca7cba1b2ee8405a1dc7cd", "documentTitle": "AstraZeneca | Results Presentation Deck | 38 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "appendix_data", "function": "analyze_data", "notes": "Data presented as stacked bar charts with corresponding data tables below each chart.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-5087-71ae-b0e8-0abfd1317859/38", "deckHref": "/decks/019de077-5087-71ae-b0e8-0abfd1317859", "deckAnchorHref": "/decks/019de077-5087-71ae-b0e8-0abfd1317859#slide-38", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }